Screening dialysis patients for vascular calcification

Seminars in Dialysis

Volumn 23, Issue 3, 2010, Pages 271-276

  Block, Geoffrey A ^a  

^a Denver Nephrologists   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CALCINOSIS; CHRONIC KIDNEY FAILURE; DISEASE COURSE; HUMAN; MASS SCREENING; METHODOLOGY; PRACTICE GUIDELINE; PREVALENCE; RENAL REPLACEMENT THERAPY; RISK FACTOR; COMPLICATION; KIDNEY FAILURE, CHRONIC; PROCEDURES;

CALCINOSIS; DISEASE PROGRESSION; HUMANS; KIDNEY FAILURE, CHRONIC; MASS SCREENING; PRACTICE GUIDELINES AS TOPIC; PREVALENCE; RENAL DIALYSIS; RISK FACTORS;

EID: 77955160334     PISSN: 08940959     EISSN: 1525139X     Source Type: Journal    
DOI: 10.1111/j.1525-139X.2010.00727.x     Document Type: Article

References (29)

1. Hardcastle JD, Chamberlain JO, Robinson MH, Moss SM, Amar SS, Balfour TW, James PD, Mangham CM. Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet 1996, 348:1472-1477.
2. Henrich WL. Optimal cardiovascular therapy for patients with ESRD over the next several years. Clin J Am Soc Nephrol 2009, 4(Suppl. 1):S106-S109.
3. Parker TF, Glassock RJ, Steinman TI. Conclusions, consensus, and directions for the future. Clin J Am Soc Nephrol 2009, 4(Suppl. 1):S139-S144.
4. de Jager DJ, Grootendorst DC, Jager KJ, van Dijk PC, Tomas LM, Ansell D, Collart F, Finne P, Heaf JG, DeMeester J, Wetzels JF, Rosendaal FR, Dekker FW. Cardiovascular and noncardiovascular mortality among patients starting dialysis. JAMA 2009, 302:1782-1789.
5. Moe SM, Chen NX, Seifert MF, Sinders RM, Duan D, Chen X, Liang Y, Radcliff JS, White KE, Gattone VH. A rat model of chronic kidney disease-mineral bone disorder. Kidney Int 2009, 75:176-184.
6. Giachelli CM. The emerging role of phosphate in vascular calcification. Kidney Int 2009, 75:890-897.
7. Shroff RC, McNair R, Skepper JN, Figg N, Schurgers LJ, Deanfield J, Rees L, Shanahan CM. Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification. J Am Soc Nephrol 2009, 21.
8. Sigrist MK, Taal MW, Bungay P, McIntyre CW. Progressive vascular calcification over 2 years is associated with arterial stiffening and increased mortality in patients with stages 4 and 5 chronic kidney disease. Clin J Am Soc Nephrol 2007, 2:1241-1248.
9. London GM. Bone-vascular axis in chronic kidney disease: a reality? Clin J Am Soc Nephrol 2009, 4:254-257.
10. London GM, Guerin AP, Marchais SJ, Metivier F, Pannier B, Adda H. Arterial media calcification in end-stage renal disease: impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003, 18:1731-1740.
11. London GM, Marchais SJ, Guerin AP, Boutouyrie P, Metivier F, de Vernejoul MC. Association of bone activity, calcium load, aortic stiffness, and calcifications in ESRD. J Am Soc Nephrol 2008, 19:1827-1835.
12. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007, 71:438-441.
13. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindberg J, Dreisbach A, Raggi P. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005, 68:1815-1824.
14. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001, 38:938-942.
15. Budoff MJ, Nasir K, McClelland RL, Detrano R, Wong N, Blumenthal RS, Kondos G, Kronmal RA. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009, 53:345-352.
16. Budoff MJ, Shaw LJ, Liu ST, Weinstein SR, Mosler TP, Tseng PH, Flores FR, Callister TQ, Raggi P, Berman DS. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007, 49:1860-1870.
17. Detrano R, Guerci AD, Carr JJ, Bild DE, Burke G, Folsom AR, Liu K, Shea S, Szklo M, Bluemke DA, O'Leary DH, Tracy R, Watson K, Wong ND, Kronmal RA. Coronary calcium as a predictor of coronary events in four racial or ethnic groups. N Engl J Med 2008, 358:1336-1345.
18. Fletcher SW. Evidence based approach to prevention. The Essentials 2005, 147-167. Basow DW. ed, Clinical Epidemiology, 4th ed. Baltimore, MD: Lippincott Williams & Wilkins
19. Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman RP, Block GA, Raggi P. Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006, 70:1623-1628.
20. Kauppila LI, Polak JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW. New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25-year follow-up study. Atherosclerosis 1997, 132:245-250.
21. Muntner P, Ferramosca E, Bellasi A, Block GA, Raggi P. Development of a cardiovascular calcification index using simple imaging tools in haemodialysis patients. Nephrol Dial Transplant 2007, 22:508-514.
22. Tonelli M, Wang W, Hemmelgarn B, Lloyd A, Manns B. Phosphate removal with several thrice-weekly dialysis methods in overweight hemodialysis patients. Am J Kidney Dis 2009, 54:1108-1115.
23. Penne EL, van derWeerd NC, van den Dorpel MA, Grooteman MPC, Levesque R, Nube MJ, Bots ML, Blankestijn PJ, ter Wee PM. Short-term effects of online hemodiafiltration on phosphate control: a result from the randomized controlled Convective Transport Study (CONTRAST). Am J Kidney Dis 2010, 55:77-87.
24. Moe SM, Drueke TB, Block GA, Cannata-Andia JB, Elder GJ, Fukagawa M, Jorgetti V, Ketteler M, Langman CB, Levin A, MacLeod AM, McCann L, McCullough PA, Oh SM, Yee-Moon Wang A, Weisinger JR, Wheeler DC. KDIGO Clinical Practice Guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease-mineral and bone disorder (CKD-MBD). Kidney Int 2009, 76:1-140.
25. Block GA, Klassen PS, Lazarus JM, Ofsthun N, Lowrie EG, Chertow GM. Mineral metabolism, mortality, and morbidity in maintenance hemodialysis. J Am Soc Nephrol 2004, 15:2208-2218.
26. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB, Goodman WG. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. N Engl J Med 2004, 350:1516-1525.
27. Jamal SA, Fitchett D, Lok CE, Mendelssohn DC, Tsuyuki RT. The effects of calcium-based versus non-calcium-based phosphate binders on mortality among patients with chronic kidney disease: a meta-analysis. Nephrol Dial Transplant 2009, 24:3168-3174.
28. St Peter WL, Fan Q, Weinhandl E, Liu J. Economic evaluation of Sevelamer versus calcium-based phosphate binders in hemodialysis patients: a secondary analysis using Centers for Medicare & Medicaid Services Data. Clin J Am Soc Nephrol 2009, 4:1954-1961.
29. Mathew T, Corso O. Review article: early detection of chronic kidney disease in Australia: which way to go? Nephrology (Carlton) 2009, 14:367-373.